Cargando…
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
Autores principales: | Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuqi, O’Dorisio, M. Sue, Waschek, James A., Tan, Yossan-Var |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544977/ https://www.ncbi.nlm.nih.gov/pubmed/28778207 http://dx.doi.org/10.1186/s12974-017-0927-1 |
Ejemplares similares
-
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage
por: Abad, Catalina, et al.
Publicado: (2016) -
Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE
por: Tan, Yossan-Var, et al.
Publicado: (2013) -
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
por: Becquet, Laurine, et al.
Publicado: (2019) -
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses
por: Abad, Catalina, et al.
Publicado: (2012) -
Correction: VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses
por: Abad, Catalina, et al.
Publicado: (2013)